Why Senomyx, Northwest Biotherapeutics, and Boyd Gaming Are Today's 3 Best Stocks

The S&P 500 ends decisively lower, but that didn't stop Senomyx, Northwest Biotherapeutics, or Boyd Gaming from soaring by double-digits.

Mar 11, 2014 at 5:15PM

Despite a second straight day of light economic data, investors today took their cues to lock in their gains and pushed the broad-based S&P 500 (SNPINDEX:^GSPC) decisively lower.

The big issue that continues to haunt the market on a daily basis is the mounting standoff between Russia and Ukraine. Some estimates show that a conflict in this region could drastically reduce Russia's GDP growth, which would negatively affect the rest of the industrialized nations around the world, including the United States. Russia is a vital member of the BRIC nations that the U.S. is relying on to help grow its own exports, and mounting tensions between the Washington and Moscow could harm global growth if those exports are impacted.

Data to keep your eyes on for later this week includes weekly initial jobless claims and retail sales on Thursday, as well as the Bureau of Labor Statistics' Producer Price Index and the University of Michigan consumer sentiment index on Friday. Although the weather has been brutal across much of the nation, the expectation from economists is that the data should be dramatically better from last month.

For today, though, investors were more than content to take money off the table, sending the S&P 500 lower by 9.54 points (-0.51%) to close at 1,867.63. Despite the drop, the S&P still sits less than 1% from a new all-time high.

Leading all stocks to the upside today was flavor ingredients developer Senomyx (NASDAQ:SNMX), which soared 17.2% after the Food and Drug Administration found its Sweetmyx flavor ingredient to be generally recognized as safe. Senomyx has geared Sweetmyx to be used in beverages where sugar content has been reduced, but which still keeps the beverage sweet-tasting. Senomyx's partner PepsiCo (NYSE:PEP) will now be able to pursue the commercialization of Sweetmyx, which could result in new low-calorie beverages for the carbonated and still beverage giant. For Senomyx, it could represent the start of a valuable revenue stream, while for PepsiCo it might help jump-start its stagnant U.S. growth.

Clinical-stage biopharmaceutical company Northwest Biotherapeutics (NASDAQ:NWBO) soared for a second straight day, this time up 16.9%, following yesterday's positive news that its lead drug, DCVax-L had been granted a hospital exemption in Germany for use in all types of glioma brain cancers. This five-year term approval gives Northwest an opportunity to generate revenue from DCVax-L and also allows it a chance to highlight the product in a number of glioma brain cancers that are outside the realm of its current U.S. trial. While I still agree wholeheartedly that this is good news, the magnitude of the rise just doesn't make a lot of sense, and I would suggest investors wait for the U.S. phase 3 data before attempting to chase this stock any higher.

Finally, casino, resort, and gaming products operator Boyd Gaming (NYSE:BYD) vaulted higher by 16.5% after hedge fund Elliott Management disclosed in a regulatory filing that it had obtained 4.99% of Boyd's outstanding shares and had additional exposure of 2.05% through derivatives. The filing notes Elliott Management's intention to talk with Boyd's management team about possible strategic alternatives which have the potential to unlock shareholder value. On the other side of the coin, though, research firm Janney Capital commented that Boyd Gaming shares appear a bit pricey. I happen to agree with Janney here given that Boyd is valued at 33 times forward earnings and the best casino growth can be found right now outside the United States.

Senomyx, NW Bio, and Boyd Gaming are all soaring today -- but even they could struggle to keep up with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

The Motley Fool owns shares of, and recommends PepsiCo. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers